International Clinical Trial: Post-hoc analysis of Myopia progression after discontinuation of Atropine sulfate (DE-127) ophthalmic solution in the Phase II/III clinical trial in Japan

Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (JPRN-UMIN000058693) titled 'Post-hoc analysis of Myopia progression after discontinuation of Atropine sulfate (DE-127) ophthalmic solution in the Phase II/III clinical trial in Japan' on Aug. 4.

Study Type: Others,meta-analysis etc

Study Design: Not selected Not selected

Primary Sponsor: Santen Pharmaceutical Co., Ltd.

Condition: Myopia

Recruitment Status: Not Recruiting

Phase: Not selected

Date of First Enrollment: 2025/08/04

Target Sample Size: 211

Countries of Recruitment: Japan

To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000067087

Published by HT Digital Content Services with...